Fran Olson Board of Directors Fran most recently served as Sr. Vice President of Sales and Marketing at Rigel Pharmaceuticals, Inc. in San Francisco, CA. She has extensive experience leading commercial organizations that focus on developing therapies and support services for individuals with rare disorders in the neurological and autoimmune areas. She led large multidisciplinary teams to develop and deliver support services for positive patient outcomes while achieving strategic business objectives. In her early career, she was a pharmacist working directly with patients and families across a number of disease states, offering personal consulting and recommendations for optimum health. She managed a mail-order pharmacy to support patients’ individual needs in managing complex therapies and adhering to the prescribed therapies. Fran understands the complex needs of individuals living with chronic disorders, many of which begin in early life/childhood. She understands healthcare systems and patient advocacy groups along with the complexities of operating within highly regulated environments.
press release | September 1, 2026 Study: Catalight’s Family Wellbeing Scale Works Across Cultures for Families of People with Autism and Other Developmental Disabilities Read press release
case study | August 25, 2026 Maine’s RUBI Pilot Expands Access to Meaningful Autism Care Throughout the State Read case study
in the news | August 4, 2026 Future Leader: Brianna Fitchett, Vice President of Clinical Impact, Catalight Read News
in the news | July 22, 2026 Inside NSAP’s Effort to Create an All-Encompassing Autism Therapy Advocacy, Standards Organization Read News
press release | July 15, 2026 Catalight Academy Online Learning Platform Launches Courses for Parents of Autistic Youth Read press release
press release | June 17, 2026 Catalight Academy Reinforces Global Education Offerings with New Accreditations Read press release